Forum LABO Paris 2027

FRANCE BIOLEAD

Mar 25, 2027 — 10:00 am - 10:45 AM
Salle Marie Curie

Description

More information coming soon

Suggested sessions

Salle Marie Curie
Mar 23, 2027
2:00 PM3:00 PM
Biotechnology, science and healthcare of tomorrow

Inside the Joint Laboratory Service

Description
The Joint Laboratory Service stands out for its unique way of operating, making it a network of official laboratories at the heart of government action. It works for several government bodies on an extremely wide range of issues, from toys to narcotics, from verifying the accuracy of claims to food safety, as well as checking geographical origins and the naturalness of ingredients. Its scope of expertise covers 29 scientific fields and includes handling samples collected by inspection authorities, both for high-volume routine analyses (for example, pesticide residues in imported fruit and vegetables) and for in-depth expert investigations on specific topics (for example, the structural elucidation of new psychoactive substances using NMR and high-resolution mass spectrometry).
Le Service Commun des Laboratoire
Salle Marie Curie
Mar 23, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

Hemarina – a human, scientific and entrepreneurial adventure

Description
Oxygen is essential to life, and hemoglobin is the molecule responsible for transporting almost all of the oxygen present in the circulatory system of most living species. During this conference, our speaker will retrace the story of the discovery of a natural extracellular hemoglobin called M101, derived from a marine organism, Arenicola marina, and its applications in medicine. This non-allergenic and non-immunogenic molecule carries 40 times more oxygen than HbA and is 250 times smaller than a red blood cell. Its intrinsic properties make it a broad-spectrum therapeutic tool for ensuring effective tissue oxygenation in various clinical situations where ischemia and/or anemia are the triggering factors. The applications of the M101 molecule are almost limitless, as it can potentially act wherever oxygen is needed: in composite tissue transplants (organs, skin, face, limbs, etc.), during vaso-occlusive crises in patients with sickle cell disease, in cases of myocardial infarction, cerebral ischemia, in oncology (radiotherapy, CAR-T cells for hypoxic tumors), in the development of oxygenating dressings for hypoxic wounds, and in the treatment of periodontal diseases. This presentation will provide an overview of the development of the M101 molecule and its various therapeutic applications.
HEMARINA
Agora
Mar 23, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

SFSTP +POLEPHARMA

Description
Information coming soon
Atelier Exposant - Salle 2
Mar 24, 2027
11:00 AM11:45 AM
Biotechnology, science and healthcare of tomorrowInnovation and scientific valorization

La DSC : comprendre les propriétés thermiques des matériaux pour mieux maîtriser leurs performances

Speakers:
Jordan LevasseurAnton PaarIngénieur d’application en Rhéologie et en Analyse thermiquePatrick Pires ContiAnton PaarIngénieur d’application en Rhéologie et en Analyse thermique
Description
DSC: leveraging thermal properties to better understand materials Thermal properties play a decisive role in the quality, performance, and lifespan of materials. Yet differential scanning calorimetry (DSC) is still too often limited to the simple measurement of a melting temperature or glass transition. Through this Lab Meeting, Anton Paar offers practical training designed to explain the principles of DSC and, above all, to help participants make full use of the information it provides. Attendees will learn how to interpret a thermogram, select the right experimental parameters, and use DSC as a genuine decision-support tool in R&D, quality control, and expert analysis. The aim of this initiative is to show that DSC can do far more than measure characteristic temperatures. It helps characterize materials, monitor chemical reactions, compare formulations, assess the impact of manufacturing processes, verify product compliance, and detect ageing or degradation phenomena. The training also highlights the complementarities between DSC, TGA, TMA, and DMA, helping users identify the most relevant technique for their specific needs. Numerous industrial examples will illustrate these applications in polymers, petrochemicals, pharmaceuticals, food processing, construction materials, and chemicals. Participants will see in particular how to measure crystallinity, glass transition, polymorphism, oxidative stability, cross-linking reactions, purity, as well as starch gelatinization and the thermal behavior of chocolate. At the end of this presentation, laboratories will have practical keys to better understand their materials, optimize their processes, strengthen their quality control, and unlock the full potential of differential scanning calorimetry in their day-to-day activities.
ANTON PAAR FRANCE
Agora
Mar 24, 2027
12:00 PM12:45 PM
Biotechnology, science and healthcare of tomorrow

New approaches to biopharmaceutical analysis - AFSEP

Speakers:
Prof. Davy GUILLARMEUniversité de Lyon / Université de GenèveDocteur en chimie analytique et Professeur associé
Description
Biopharmaceutical drugs are playing an increasingly important role in the pharmaceutical industry. This evolution is accompanied by a wide diversity of molecules, including monoclonal antibodies and their derivatives, oligonucleotides, messenger RNA, as well as cell and gene therapies. Their size, structure, and complexity make their analysis particularly challenging. Yet in-depth characterization is essential to verify their identity, purity, and integrity, detect variants and impurities, and better understand the links between their properties and their biological activity. This presentation will first cover the main families of biopharmaceuticals and the analytical challenges they raise. It will then show how different chromatographic approaches, with or without mass spectrometry, can contribute to their characterization. Examples will illustrate the complementarity of chromatographic modes, the development of rapid analyses, coupling with MS, and method automation. Finally, the biopharmaceuticals of tomorrow are expected to become even more complex, particularly with the rise of conjugated molecules combining several types of compounds. This evolution will require the continued development of adapted analytical strategies capable of providing ever more comprehensive and reliable information.
AFSEP
Atelier Exposant - Salle 2
Mar 24, 2027
2:15 PM2:45 PM
Biotechnology, science and healthcare of tomorrowInnovation and scientific valorization

Capture More: Improving Sensitivity and Accuracy in cfDNA Sequencing

Speakers:
Valentina LO REOZYMEChef de produits biologie moléculaire - TransfectionLeonie REDTZymo Research Europe GmbHScientific Support Manager
Description
Capture More: Improving Sensitivity and Accuracy in cfDNA Sequencing Liquid biopsy offers a minimally invasive way to investigate disease-associated changes through circulating cell-free DNA (cfDNA), with applications in cancer detection, tissue-of-origin analysis and disease monitoring. However, cfDNA is scarce, highly fragmented and heterogeneous, making efficient recovery and reliable library preparation essential for sensitive and accurate analysis. This presentation focuses on an integrated workflow addressing two key challenges. - First, special magnetic-bead extraction chemistry enables recovery of a broad cfDNA size range. This includes very short fragments that are often missed by conventional extraction methods, although they can contain important information. - Second, a native-end-preserving library preparation strategy based on Splinted Ligation Adapter Tagging (SPLAT) enables direct adapter ligation without end repair. By avoiding enzymatic modification of DNA ends, this approach helps preserve native fragment termini, reduce processing-related biases and retain valuable information from short, nicked or damaged molecules. For epigenetic studies, the workflow can be complemented by whole-genome bisulfite sequencing (WGBS), enabling genome-wide DNA methylation profiling from low-input cfDNA. Together, these approaches provide access to complementary layers of information beyond genetic alterations, including fragment lengths, native DNA ends and methylation patterns. Combining these insights may support more sensitive and informative approaches to early cancer detection, tissue-of-origin analysis and disease monitoring. Key Takeaways • Recover more: Capture a broader range of cfDNA fragment sizes, including very short fragments. • Preserve more: Avoid end repair to retain native DNA ends and minimize processing-related biases • Discover more: Combine genetic, epigenetic and fragmentomic insights through complementary sequencing approaches.
OZYME